New Jersey Healthcare Blog

MARCH 8, 2022

For 2023 the healthcare cost growth benchmark is 3.5%, for 2024 3.2%, for 2025 3%, for 2026 2.8%, for 2027 2.8%. d), to permit the Committee to count clinical hours obtained before the submission of the proposed plan of supervision toward the number of supervised hours required to become a licensed counselor. See proposed N.J.A.C.

Telemedicine 40

Telemedicine COVID-19 Licensing Nurses 40

HIT Consultant

AUGUST 23, 2022

First, because it requires little to no upfront spend on hardware and licensing. Finally, it’s worth noting the growing popularity of hybrid cloud solutions – the market for which is forecast to triple in value from 2020 to 2026, rising from $52 to $145 billion. Why is cloud cheaper than on-premises storage?

Electronic Medical Records 98

Electronic Medical Records HIPAA Compliance Telemedicine 98

SQA

FEBRUARY 15, 2023

Finalization of the document is planned for 2026. ACT EU features ten priority action areas that are the basis for the ACT EU 2022-2026 workplan. The consultation period for the revised new Annex 11 ends on 16 January 2023, with a draft document to be released for consultation in December 2024. was conducted on 07 November 2022.

US Department of Health and Human Services 40

US Department of Health and Human Services FDA COVID-19 World Health 40

Hall Render

MAY 10, 2024

Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’

Nursing Homes 40

Nursing Homes Nurses Hospitals Medicaid 40

C&M Health Law

JANUARY 4, 2024

The United States Core Data for Interoperability Version 3 (USCDI v3): ONC established the USCDI v3 as the new baseline standard of data classes and constituent data elements for certified health IT, effective January 1, 2026.

Public Health 52

Public Health Licensing HIPAA Governance 52

SQA

MAY 24, 2023

The company did not have a written procedure in place for the provision of information related to serious risk of injury to health, contrary to what was committed to on it establishment license application. The name and address of manufacturers provided by the company on its establishment license application were not accurate.

FDA 40

FDA Licensing Governance Compliance 40

Hall Render

DECEMBER 1, 2023

to Recruit, Train Primary Care Students UAMS Gets $17.5M to hospitals Propella Therapeutics, Pittsboro firm with 5 employees, sold for $175M Winston-Salem’s clinical research organization Javara raises $9.43

Nursing Homes 40

Nursing Homes Nurses Ransomware COVID-19 40

Hall Render

MARCH 3, 2023

million for youth mental health care KENTUCKY Pike County nursing home officials release statement following loss of Medicare agreement Three Humana executives drop $11.2M What does it mean for you?

Nursing Homes 40

Nursing Homes COVID-19 Nurses Hospitals 40

Healthcare Law Blog

AUGUST 25, 2022

The first list of up to 10 Part D negotiation-eligible drugs will be published in 2026, the earliest “price applicability date” at which the Program takes effect. The drug publication date for 2026 will be chosen by September 1, 2023. Insulin Products.

Medicare 52

Medicare Medicare Medicaid Medicaid 52

Health Law Advisor

SEPTEMBER 1, 2023

The negotiated pricing will go into effect in 2026. CMS, Medicare Drug Price Negotiation Program: Selected Drugs for Internal Price Applicability Year 2026 (Aug. These drugs are manufactured by Novo Nordisk and have their own unique Biologics Licensing Application numbers. 29, 2023).

Medicare 69

Medicare Medicare Licensing Medicaid 69

Hall Render

FEBRUARY 2, 2024

Gordon unveils plan for reforming Wyoming’s mental health system Hayse medical license reinstated Wyoming State Hospital bed shortages continue, report finds The post Health Provider News appeared first on Law Firm | Health Care Law Firm in the USA | Hall Render. for Dental Health OakLeaf Medical Network reaches out to HSHS WYOMING Gov.

Nursing Homes 40

Nursing Homes US Department of Health and Human Services Nurses Hospitals 40

Healthcare Law Blog

NOVEMBER 13, 2023

However, as all FDA-licensed biosimilar biological products must be very similar to and would have no clinically meaningful difference from the reference product with respect to safety and efficacy, CMS is comfortable with proposing this formulary change.

Medicare 59

Medicare Medicare Medicaid Medicaid 59

Healthcare Law Blog

JANUARY 5, 2023

The HEI for the 2027 Star Ratings would be calculated using data collected or used for the 2026 and 2027 Star Ratings, and would replace the current reward factor that has been in place since the 2009 Star Ratings. That is, the HEI is specifically designed to create an incentive to reduce disparities in care.

Medicare 52

Medicare Medicare Medicaid Medicaid 52